Category: MENA

Regional Ceremonies Unveil Outstanding Global Achievements Among IT Solutions Providers

CLEVELAND, OH, Feb. 08, 2024 (GLOBE NEWSWIRE) — Last night, Park Place Technologies, the leading global data center and networking optimization firm, formally announced the winners of its inaugural 2023 Channel Partner Awards program. These awards recognize the collaboration of Park Place’s network of channel partners in solving client pain points through the adoption of IT infrastructure management and optimization services.

Partners play a pivotal role in Park Place Technologies’ success, serving as a substantial driving force behind revenue generation and deal facilitation globally. Recognizing this, Park Place has committed to fostering the growth and success of its partners. The initiation of their Partner Advisory Board (PAB) in both North America and EMEA in 2023 underscores this commitment, providing a platform for communication, learning, and mutual benefit.

Furthermore, the implementation of a Channel Partner Awards program provides a platform to formally recognize organizations that contributed significantly to the organization’s success while addressing critical customer pain points. Regional ceremonies hosted in Scottsdale, Arizona and London, UK offered an opportunity to acknowledge and applaud said partners in person for their dedication and achievements throughout the previous year.

The awards constituted five categories across four regions and were open to all of Park Place Technologies’ global partners that had been onboarded by January 1st, 2023. The awards titles and recipients by region were as follows:

2023 Partner of the Year
Awarded to the partners that transacted the largest total revenue contribution to Park Place Technologies between January 1, 2023, and December 31, 2023. Title winners by region include:

• • North American Partner of the Year – CDW Corporation
  • Asian-Pacific Partner of the Year – DXC Technology
  • European, Middle Eastern, and African Public Sector Partner of the Year – Insight
  • European, Middle Eastern, and African Commercial Partner of the Year – Softcat
  • Latin American Partners of the Year:
    • North of Latin America Region Partner of the Year – BPM @ Consulting
    • Southern Cone Region Partner of the Year – Telextorage
    • Andean Region Partner of the Year – Green Services and Solutions

2023 Rising Star Partner of the Year
Recognizing partners onboarded in 2022 that have showcased their partner potential in delivering live opportunities, have actively collaborated in partnership with Park Place, and have demonstrated YoY growth from the previous 12 months, between January 1, 2023, and December 31, 2023. Title winners by region include:

• • North American Rising Star Partner of the Year – Lucidia IT
  • Asian-Pacific Rising Star Partner of the Year – Galaxy Office Automation
  • European, Middle Eastern, and African Rising Star Partner of the Year – Renewtech
  • Latin American Rising Star Partners of the Year:
    • North of Latin America Region Rising Star Partner of the Year – Sonda
    • Southern Cone Region Rising Star Partner of the Year – Vr4
    • Andean Region Rising Star Partner of the Year – IO Gestion

2023 Collaborative Partner of the Year
Acknowledging partners that have demonstrated true collaboration, working with Park Place Technologies to solve customer pain points and devise solutions, being advocates for Park Place’s range of IT infrastructure management services, and have advanced the co-operations between our sales and technical teams across our entire portfolio. Title winners by region include:

• • North American Collaborative Partner of the Year – SHI International Corp
  • Asian-Pacific Collaborative Partner of the Year – Phil-Data Business Systems Inc
  • European, Middle Eastern, and African Collaborative Partner of the Year – Viadex
  • Latin American Collaborative Partners of the Year:
    • North of Latin America Region Collaborative Partner of the Year – Openstor
    • Southern Cone Region Collaborative Partner of the Year – Ricoh Chile
    • Andean Region Collaborative Partner of the Year – Terasys

2023 Partner Initiative of the Year
Awarded to the partners that have collaborated with Park Place Technologies to deliver a stand-out initiative. This initiative either aligns their partner sales teams with Park Place, or actively promotes Park Place’s portfolio of services to their end-user customers, resulting in demonstratable alignment with Park Place and our portfolio of services. Key criteria included total number of aligned reps and opportunities per rep worked in conjunction with Park Place sellers. Title winners by region include:

• • North American Partner Initiative of the Year – CDW Corporation
  • Asian-Pacific Partner Initiative of the Year – Information System Services Co. (Japan)
  • European, Middle Eastern, and African Partner Initiative of the Year – Constor Solutions
  • Latin American Partner Initiative of the Year – Sdelka

2023 Partner Deal of the Year
Recognizing the partners responsible for delivering the single largest deal opportunity to Park Place Technologies between January 1, 2023, and December 31, 2023. Title winners by region include:

• • North American Partner Deal of the Year – Technologent
  • Asian-Pacific Partner Deal of the Year – DXC Technology
  • European, Middle Eastern, and African Partner Deal of the Year – Softcat

Chad Jones, Senior Director of Partner Sales at Park Place Technologies, expressed his gratitude, stating, “On behalf of Park Place Technologies, I am proud to recognize our strategic partners for their enthusiasm and commitment to scaling business within their end-user accounts.”

“The five award categories in our 2023 inaugural Partner Awards were derived from Park Place’s channel program initiatives, such as portfolio adoption and sales rep engagement,” he continued. “2023 was a banner year for Park Place, and specifically our Channel division, which saw historic growth in bookings and revenue across all business segments.”

About Park Place Technologies

Park Place Technologies is a global data center and networking optimization firm. We help more than 21,000 clients optimize data center budgets, productivity, performance, and sustainability so they can think bigger – and act faster. From procurement to decommissioning, our comprehensive portfolio of services and products helps IT teams optimize IT lifecycle management. This frees time and spend so they can focus on transforming their businesses for the future.

Park Place’s industry-leading and award-winning services portfolio includes Park Place Hardware Maintenance, Park Place Professional Services, ParkView Managed Services, Entuity Software and Curvature Hardware sales. For more information, visit www.parkplacetechnologies.com. Park Place is a portfolio company of Charlesbank Capital Partners and GTCR.

Attachment

• Park Place Technologies Headquarters

Michael Miller
Park Place Technologies
440-683-9426
[email protected]

GlobeNewswire Distribution ID 9033943

Deal reaffirms Mundo Verde Climate’s role as a leading global provider of carbon credits and helps to stimulate the voluntary market, which is set for a resurgence following COP28.

Geneva, Feb. 05, 2024 (GLOBE NEWSWIRE) — Mundo Verde Climate, a global player in climate finance and climate change risk management advisory, announced its pivotal role in one of the most significant transactions of 2023 within the global voluntary carbon market. The company, dedicated to forging a sustainable future for generations, continues to champion green technologies and nature-based solutions in the race to Net Zero.

In a significant stride towards achieving this goal, Mundo Verde Climate has entered into a strategic arrangement with Biotrend Enerji, the most prominent player in the Turkish integrated waste management, waste-to-energy and circular plastics market. This collaboration marks a milestone in the pursuit of mobilizing finance towards new climate change mitigation technologies.

Mundo Verde Climate took an instrumental role in developing the voluntary carbon units from Biotrend’s waste to energy activities through a certification and verification process under VERRA.  The transaction, covering over 2.4 million tons of CO2 in total, refers to voluntary carbon credits for release on the international market. Companies can acquire the credits to offset their emissions from unrelated activities.

The deal promises to impact the global voluntary carbon market substantially. Mundo Verde Climate, together with Biotrend, hopes that the initiative will provide much-needed carbon credits to satisfy demand in the voluntary offsetting market and inspire others to advance their projects and stimulate the market.

Reflecting on the efforts of governments at COP 28 to invigorate the global trade in voluntary carbon credits, Ms Gediz Kaya, Managing Partner at Mundo Verde Climate, expressed enthusiasm about the Biotrend arrangement, stating:

“According to Climate Policy Initiative, the amount of financing needed to be mobilized towards climate mitigation technologies by 2030 is $4.3 trillion annually and 21% of that finance is mobilized right now. So we need to take action and we need to decarbonize as fast as possible. This collaboration exemplifies our dedication to fostering international cooperation and collaboration of key industries in pricing carbon so that we can mobilize finance in the fight against climate change. By joining forces with Biotrend, we aim to catalyse transformative change and encourage companies in the energy sector, and other industries, to adopt a sustainable approach to managing their emissions.”

The COP28 summit in the United Arab Emirates discussed a number of important factors related to standards and integrity around carbon crediting and recognized the important role of voluntary carbon markets in addressing climate change. Mundo Verde Climate underscores the urgency of global collaboration to address climate challenges and calls for renewed efforts, partnerships, and commitments to mobilize finance. This is vital for accelerating the transition to a low-carbon economy.

Biotrend made a related public disclosure about certified carbon crediting on 8 November 2023, in its 9-month financial statement.

Attachments

• Gediz Kaya
• Mundo Verde Climate logo

Mundo Verde Climate
[email protected]

GlobeNewswire Distribution ID 9032182

• Automobili Pininfarina begins 2024 with multiple award wins for its design
• PURA Vision awarded Silver in Conceptual Products / Automotive & Transport Product Design category at The International Design Awards
• Automobili Pininfarina named ‘Luxury Electric Performance Car Manufacturer of the Year 2024’ by LUXlife Magazine
• Battista Edizione Nino Farina crowned Best Electric Hypercar at Robb Report Monaco & Côte d’Azur Car of the Year 2024
• Full suite of assets to support the news can be found here

CAMBIANO, Italy, Feb. 06, 2024 (GLOBE NEWSWIRE) — Automobili Pininfarina has kicked off 2024 with three award wins, as it continues to build on the success of a record-breaking previous year.

LUXlife Magazine named Automobili Pininfarina ‘Luxury Electric Performance Car Manufacturer of the Year 2024’ at its annual awards.

Celebrating the unparalleled achievements and exceptional creativity in the realm of luxury, LUXlife awards honour the leaders and pioneers who redefine excellence within the industry, setting higher standards of sophistication and elegance. Automobili Pininfarina was a winner within the ‘Leaders in Luxury’ category.

This was followed by another win for the PURA Vision design concept, which was awarded Silver in Conceptual Products / Automotive & Transport Product Design at the 2024 International Design Awards.

Battista Edizione Nino Farina

PURA Vision represents the beginning of what promises to be a groundbreaking era for electric luxury vehicles and was penned by Chief Design Officer, Dave Amantea. It was unveiled at 2023 Monterey Car Week.

Dave Amantea, Chief Design Officer, commented: “Our PURA design philosophy is all about simplicity and timeless beauty, which is designed into every Automobili Pininfarina model. The elegant silhouette and dramatic proportions express this language on PURA Vision, envisioned here as a first-of-its-kind electric Luxury Utility Vehicle (e-LUV).”

The principles of the PURA philosophy, established by Automobili Pininfarina, transform the DNA of iconic models from Pininfarina SpA’s past to define the future, balancing inspiration from iconic classic cars with futuristic elements.

Inspired by classic proportions and exquisite detailing, PURA Vision presents an elegant silhouette with bold cab-rear proportions that combine timeless beauty with exquisite detailing to create a dynamic identity with unmistakable presence. Show-stopping features include its narrow glasshouse and tri-opening pillarless doors, which provide supreme access to its sophisticated cabin.

PURA Vision design concept

Most recently, the Automobili Pininfarina Battista Edizione Nino Farina was named Best Electric Hypercar at Robb Report Monaco & Côte d’Azur Car of the Year 2024. Introduced at the 2023 Goodwood Festival of Speed, it is a tribute to racing legend Nino Farina – nephew of company founder Battista ‘Pinin’ Farina and the first Formula One World Champion.

Each of the five unique examples features an exquisite detail that references a different milestone in Nino’s racing career. Finished in a bespoke Rosso Nino paint complemented by a special livery on the lower body, finished in Bianco Sestriere and Iconica Blu, the exterior design is completed by the Satin Gold 10-spoke forged aluminium Glorioso alloy wheels.

Press Contacts

Duncan Forrester Chief Communications Officer (M) +49 (0) 171 265 4094 d.forrester@automobili-pininfarina.com

Akira Shinonuma Communications Manager (M) +49 (0) 1511 0949270 a.shinonuma@automobili-pininfarina.com

FOR MORE INFORMATION, VISIT
https://automobili-pininfarina.com/media-hub

EDITOR’S NOTES

ABOUT AUTOMOBILI PININFARINA
Automobili Pininfarina is based in operational headquarters in Munich, Germany, with a team of experienced automotive executives from luxury and premium car brands. Designed, engineered and produced by hand in Italy, the Battista hyper GT and all future models will be sold in all major global markets under the brand name Pininfarina. The company aims to design experiences for the world’s foremost taste makers. Automobili Pininfarina GmbH is a 100 per cent Mahindra & Mahindra Ltd investment following the signing of a trademark licence agreement between Pininfarina S.p.A. and Mahindra & Mahindra Ltd. Pininfarina S.p.A. has an influential role in supporting design and production capacities based on its unique 94-year experience of producing many of the world’s most iconic cars.

Photos accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/666e6473-ad48-44a4-b8b4-63370c5905ba
https://www.globenewswire.com/NewsRoom/AttachmentNg/4e3f2da6-e216-479c-97fd-4f672a1d3e87
https://www.globenewswire.com/NewsRoom/AttachmentNg/5528a50f-f9b1-44f9-8a6f-86535076509

GlobeNewswire Distribution ID 1000912151

Curia recognized for its Service in the CDMO industry

ALBANY, N.Y., Feb. 05, 2024 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced it has been awarded a 2024 CDMO Leadership Award in the Service category, Small Pharma group. In its 13^th year, the awards are presented by Outsourced Pharma and Life Science Leader.

“Curia is honored to receive this award,” said Philip Macnabb, CEO, Curia. “This distinction underscores our commitment to creating value for our customers across all of our R&D and manufacturing offerings, and we are especially appreciative to be acknowledged by the partners we support for that commitment.”

Winners of CDMO Leadership Awards are selected based on market research by Industry Standard Research (“ISR”) to distinguish CDMOs that meet or exceed customer expectations. For the 2024 awards, 98 contract manufacturers were evaluated by 23 performance metrics in ISR’s annual Contract Manufacturing Quality Benchmarking survey. Respondents to the survey only evaluate companies with which they have worked on an outsourced project within the past 18 months. Curia was awarded based on the feedback of respondents in the Small Pharma category.

“Congratulations to our 2024 CDMO Leadership Award winners. By vote of your customers, you are recognized as the best in the global outsourcing development and manufacturing sector of the biopharma industry,” says Louis Garguilo, Chief Editor and Conference Chair, Outsourced Pharma. “Award winners maintained and expanded capabilities and expertise to meet the needs of a diverse customer base; provided the additional quality and reliability so crucial to novel processes and products; and forged the closest relationships with customers. 2023 rang in with many unsettled questions. The 2024 CDMO Leadership Award winners are the support companies that best answered the bell over the past year.”

About Curia
Curia is a Contract Development and Manufacturing Organization (CDMO) with over 30 years of experience, an integrated network of 27 global sites and over 3,500 employees partnering with Biopharmaceutical customers to bring life-changing therapies to market. Our biologics and small molecules offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to improve patients’ lives. Visit us at curiaglobal.com.

Corporate Contact:

Viana Bhagan

Curia

+1 518 512 2111

corporatecommunications@CuriaGlobal.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/328a3a12-3a66-4a34-bdc8-e5de362efb85

GlobeNewswire Distribution ID 9031149

RIYADH, Saudi Arabia, Feb. 05, 2024 (GLOBE NEWSWIRE) — In a major scientific breakthrough, a research team from King Faisal Specialist Hospital and Research Centre (KFSH&RC), in collaboration with King Abdullah University of Science and Technology (KAUST), working alongside researchers from the UK, the US, and India, discovered a vital gene instrumental in combating malaria. This gene, termed PfAP2-MRP, is essential in the replication process of Plasmodium falciparum, the parasite that causes the most lethal strain of malaria.

Advanced laboratory techniques enabled the researchers to inhibit the PfAP2-MRP gene, revealing its critical role in the malaria parasite’s life cycle within red blood cells. This inhibition significantly disrupts the parasite’s ability to reproduce, reducing the severity of the disease’s symptoms and curbing its spread. This discovery is particularly impactful as it addresses Plasmodium falciparum malaria, which claims over half a million lives annually.

Dr. Ashraf Dada, Chairman of the Department of Pathology and Laboratory Medicine at King Faisal Specialist Hospital and Research Centre in Jeddah and the lead researcher, stated: “This discovery paves the way for the development of more effective treatments for the deadliest malaria strain, Plasmodium falciparum.” Also, this study enhances the scientific community’s understanding of the disease’s progression and its interaction with the human immune system, thereby strengthening efforts to combat this widespread malaria parasite prevalent in Africa.

Furthermore, the research demonstrated that the PfAP2-MRP gene regulates the production of genetically diverse protein receptors, allowing the parasite to evade the host’s immune system. This mechanism plays a significant role in the global spread of malaria and underscores the gene’s importance in developing future therapeutic strategies.

Published in the prestigious journal “Nature” this noteworthy study is part of a close collaboration between KFSH&RC and KAUST to engage in innovative research activities aimed at not only improving the diagnosis of microbes, bacteria, and parasites, but also underscores a global effort to combat pathogens and improve human health.

King Faisal Specialist Hospital and Research Centre stands among the global leaders in providing specialized healthcare, driving innovation, and serving as an advanced medical research and education hub. Through strategic partnerships with prominent local, regional, and international institutions, the hospital is dedicated to advancing medical technologies and elevating the standards of healthcare worldwide.

About King Faisal Specialist Hospital & Research Centre (KFSH&RC):

King Faisal Specialist Hospital & Research Centre (KFSH&RC) stands as a leading healthcare institution in the Middle East, envisioned to be the optimal choice for every patient seeking specialized healthcare. The hospital boasts a rich history in the treatment of cancers, cardiovascular diseases, organ transplantation, neurosciences, and genetics.

In 2023, “Brand Finance” ranked King Faisal Specialist Hospital & Research Centre as the top academic medical centre in the Middle East and Africa, and among the top 20 globally. Additionally, in 2022, it was recognized as one of the leading global healthcare providers by Newsweek magazine.

As part of Saudi Vision 2030, a royal decree was issued on December 21, 2021, to transform the hospital into an independent, non-profit, government-owned entity, paving the way for a comprehensive transformation program aimed at achieving global leadership in healthcare through excellence and innovation.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/38b3fbef-fece-4a76-b326-2d57ab1b16ba

CONTACT INFORMATION 

For more information please contact:

Mr. Essam Al-Zahrani, Media Affairs Head, 0555254429

Mr. Abdullah Al-Awn, Media Coordination Officer, 0556294232

GlobeNewswire Distribution ID 9031968

Rancho Santa Margarita, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — Blue California, an industry leader in science-driven ingredient development, announced the successful completion of a groundbreaking human clinical trial of ergothioneine. A double-blinded placebo-controlled clinical trial sponsored by Blue California has shown that ErgoActive® ergothioneine supports aspects of cognitive function, memory, and sleep in healthy elderly subjects with subjective memory complaints.

“Blue California is proud to have sponsored such an important human study,” said Linda May-Zhang, Ph.D., VP of Science and Innovation at Blue California. “We are pleased by the results showing improvements of cognitive function and ability to get to sleep in subjects consuming ErgoActive for four months.”

Research has suggested that inadequate levels of ergothioneine are associated with a range of health problems, including cardiovascular disease, frailty, age-related cognitive decline, neurodegenerative diseases such as Parkinson’s disease, and dementias such as Alzheimer’s disease. Mushroom consumption and estimated dietary ergothioneine intake have previously been associated with reduced risk of cognitive decline and potentially longer lifespan.

Despite decades of preclinical research, association studies, and clinical studies conducted with mushrooms, it remained untested whether supplementation with pure ergothioneine can improve cognitive outcomes. Rigorous clinical studies were lacking. Today, Blue California has made a substantial advancement by sponsoring a double-blinded, placebo-controlled clinical study conducted at a national research institution.

Sharing his insights, Robert B. Beelman, Ph.D., Professor Emeritus of Food Science and Director of the Center for Plant and Mushroom Foods for Health at Pennsylvania State University, stated, “The results of this study provide important clinical evidence supporting the idea that ergothioneine is a ‘longevity vitamin’ that can help mitigate cognitive decline and sleep issues commonly associated with aging.”

Blue California is a proud gold sponsor for the National University of Singapore’s Center of Healthy Longevity global conference on Supplements for Healthy Longevity, held Feb. 29 – Mar. 2, 2024.

ErgoActive ergothioneine is made by precision fermentation with FDA-reviewed safety of GRAS. This ingredient is easy to formulate for dietary supplements, functional food and beverages, pet supplements, and cosmetics.

About Blue California Ingredients

Blue California is a science-driven, nature-inspired ingredient company dedicated to developing innovative solutions for health and well-being. We provide and manufacture clean, natural, and sustainable ingredients used in food, beverage, flavor, fragrance, dietary supplements, personal care, and cosmetic products.

With a commitment to rigorous scientific research, the company aims to address pressing concerns related to aging and healthspan.  For more information, visit https://bluecal-ingredients.com/ergothioneine.

ErgoActive® is a registered trademark of Blue California, Inc.

Ergothioneine is also referred to as L-Ergothioneine, (ET) and (ERG).

Attachments

• Blue California successfully completes groundbreaking human clinical trial of ergothioneine.
• Despite not being produced in the body, ergothioneine is present in nearly all human cells, suggesting its significance in supporting human health.

Ana Capretz, Head of Public Relations and Communications
Blue California ingredients
+1-949-635-1991
[email protected]

GlobeNewswire Distribution ID 9031565